Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -90.27% is 19% below its 5-year average of -75.93%, around the middle of its 5-year range (-159.85%–-26.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.37% above its 12-month average of -114.80%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -90.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-90.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-114.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-90.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-75.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+21.37%
CURRENT VS 3Y AVG
+0.58%
CURRENT VS 5Y AVG
-18.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.40%
median of 552 covered companies
CURRENT VS SECTOR MEDIAN
-187.53%
vs the sector median at left
Humacyte, Inc.
Market Cap
$85.14M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-114.80%
3Y Avg
-90.80%
5Y Avg
-75.93%
Market Cap
$85.24M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$85.02M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$84.75M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$83.92M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$86.43M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.09M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$87.75M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$88.04M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humacyte, Inc. (HUMA) | $85.14M | -90.27% | -114.80% | -90.80% | -75.93% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.24M | -100.35% | -639.99% | -358.78% | -266.51% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.02M | -109.43% | -208.02% | -178.83% | -203.50% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | -88.28% | -61.59% | -48.92% | -67.61% |
| MediciNova, Inc. (MNOV)vs › | $83.92M | -31.62% | -27.86% | -23.01% | -20.58% |
| Conexeu Sciences Inc. (CNXU)vs › | $86.43M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.09M | -159.30% | -82.85% | -66.58% | -50.22% |
| CareCloud, Inc. (CCLD)vs › | $87.75M | 12.79% | 17.38% | -11.40% | -8.36% |
| ImmuCell Corporation (ICCC)vs › | $88.04M | 8.16% | 0.11% | -4.79% | -3.69% |
| Citius Oncology, Inc. (CTOR)vs › | $81.82M | -88.72% | -42.77% | -39.33% | -39.33% |
ROIC
-90.3%
ROE
-309.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -90.27% |
| 2026-03-31 | -120.68% |
| 2025-12-31 | -110.35% |
| 2025-09-30 | -159.85% |
| 2025-06-30 | -92.83% |
| 2025-03-31 | -77.88% |
| 2024-12-31 | -97.01% |
| 2024-09-30 | -119.90% |
| 2024-06-30 | -88.68% |
| 2024-03-31 | -70.64% |
| 2023-12-31 | -91.13% |
| 2023-09-30 | -70.51% |
| 2023-06-30 | -59.68% |
| 2023-03-31 | -49.54% |
| 2022-12-31 | -43.76% |
| 2022-09-30 | -40.18% |
| 2022-06-30 | -35.05% |
| 2022-03-31 | -32.79% |
| 2021-12-31 | -29.48% |
| 2021-09-30 | -26.31% |
| 2021-06-30 | -87.90% |
| 2021-03-31 | -67.32% |
| 2020-12-31 | -65.98% |
